Phase 3 N=15 Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation
FSGS
Primary: Rate of Recurrence of FSGS as Seen in Renal Transplant Biopsies Proteinuria — 14 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=47 A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)
Alpha-1 Antitrypsin Deficiency (AATD)
Primary: The Proportion of Participants With Adverse Events — 8; 5; 4; 3 Participants
N/A N=144 LetSync: Pilot Test of Mobile Health (mHealth) Intervention
HIV/AIDS
Primary: Proportion of Urine Samples Returned by Participants — 54; 65 Participants
Phase 2 N=20 Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
HER2 Positive Breast Carcinoma · Stage I Breast Cancer AJCC v7 · Stage IA Breast Cancer AJCC v7
Primary: Number Participants With Neutropenia, Graded According to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version (v)4.03 — 2…
Phase 2 N=64 Early Parkinson's Disease Monotherapy With CVN424
Parkinson's Disease
Primary: Change From Baseline to Week 12 on the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II + Part III — -2.81; -2.09 score on a…
N/A N=200 SPOTFIRE Sore Throat (ST) Study
Pharyngitis, Infective
Primary: Aim 2 Clinical Outcome: Summary of Test Results — 1; 6; 14; 13 Participants
N/A N=94 Gas Exchange Kinetics and Work Load During Exercise
Methods of Exercise in Children
Primary: Maximum Oxygen Uptake (VO2) Measurements During Exercise — 1.6; 2.8; 3.2; 1.7 L/min
N/A N=6,559 A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
Osteoarthritis, Knee · Osteoarthritis, Hip
Primary: Phase II (RCT): Readmissions — 4; 4; 7; 1 Participants
Phase 2 N=56 Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Bacteremia · Staphylococcus Aureus · Staphylococcus Aureus Bacteremia
Primary: Number of Participants With Treatment-Emergent Adverse Events (Safety and Tolerability) Following Multiple Doses of Intravenous AP-Sa02. — 17; 10; 6; 2 number of…
Phase 3 N=14 Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
Adult Onset Still's Disease
Primary: Percentage of Participants Who Achieved Adapted American College of Rheumatology (ACR) 30 Response at Week 8 — 50.0 Percentage of participants
N/A N=244 Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.
Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2) · Screening Colonoscopy
Primary: Composite of Reaching the Cecum in Less Than 10 Minutes Without Changing the Scope Type. — 113; 116 Participants
Phase 2 N=49 A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo
Nonsegmental Vitiligo With Genital Involvement
Primary: Percentage of Participants Achieving a Genital Vitiligo Noticeability Scale (VNS) of "4 - A Lot Less Noticeable" or "5 - No Longer Noticeable" at Week 48 — 27.0…
Phase 2 N=261 Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Primary: Number of Participants With Treatment-Emergent Adverse Events and Treatment Emergent Serious Adverse Events — 51; 63; 62; 21 Participants
N/A N=92 Psychological Intervention for Caregivers of Patients Undergoing Stem Cell Transplant
Cancer
Primary: Feasibility of the Intervention (Feasibility Description Below) — 36 Participants
N/A N=102 Shared Decision Making in Dialysis
End Stage Renal Disease · Chronic Kidney Diseases
Primary: Mean Feasibility of Intervention Measure — 16.4; 16.1; 19.0 score on a scale